• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.05% Nasdaq Down0.18%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    0.33 Down 0.00(1.11%) 4:00PM EDT
    |After Hours : 0.33 0.00 (0.00%) 4:37PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJan 31, 2016Oct 31, 2015Jul 31, 2015Apr 30, 2015
    Total Revenue 6,709   9,523   9,671   9,308  
    Cost of Revenue3,896  4,741  4,608  4,758  
    Gross Profit 2,813   4,782   5,063   4,550  
    Operating Expenses
    Research Development15,156  14,190  13,918  11,531  
    Selling General and Administrative4,524  4,416  4,899  5,188  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (16,867) (13,824) (13,754) (12,169)
    Income from Continuing Operations
    Total Other Income/Expenses Net34  626  31  34  
    Earnings Before Interest And Taxes(16,833)(13,198)(13,723)(12,135)
    Interest Expense14   -   -   -  
    Income Before Tax(16,847)(13,198)(13,723)(12,135)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(16,847)(13,198)(13,723)(12,135)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (16,847) (13,198) (13,723) (12,135)
    Preferred Stock And Other Adjustments(1,035)(1,035)(1,378)(1,119)
    Net Income Applicable To Common Shares (17,882) (14,233) (15,101) (13,254)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.